Detailed Information on Publication Record
2024
Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ et. al.Basic information
Original name
Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes: systematic review of population-based studies
Authors
MAKOVSKI, Tatjana T, Jinane GHATTAS, Stephanie MONNIER-BESNARD, Lisa CAVILLOT, Monika AMBROŽOVÁ (203 Czech Republic, belonging to the institution), Barbora VASINOVA (203 Czech Republic), Rodrigo FETEIRA-SANTOS, Peter BEZZEGH, Felipe Ponce BOLLMANN, James COTTAM, Romana HANEEF, Brecht DEVLEESSCHAUWER, Niko SPEYBROECK, Paulo Jorge NOGUEIRA, Maria Joao FORJAZ, Joel COSTE and Laure CARCAILLON-BENTATA
Edition
AGING CLINICAL AND EXPERIMENTAL RESEARCH, NEW YORK, SPRINGER, 2024, 1594-0667
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.000 in 2022
Organization unit
Faculty of Medicine
UT WoS
001161688700002
Keywords in English
COVID-19; SARS-CoV-2; Multimorbidity; Multiple chronic conditions; Frailty
Tags
International impact, Reviewed
Změněno: 10/6/2024 12:18, Mgr. Tereza Miškechová
Abstract
V originále
BackgroundEstimating the risks and impacts of COVID-19 for different health groups at the population level is essential for orienting public health measures. Adopting a population-based approach, we conducted a systematic review to explore: (1) the etiological role of multimorbidity and frailty in developing SARS-CoV-2 infection and COVID-19-related short-term outcomes; and (2) the prognostic role of multimorbidity and frailty in developing short- and long-term outcomes. This review presents the state of the evidence in the early years of the pandemic. It was conducted within the European Union Horizon 2020 program (No: 101018317); Prospero registration: CRD42021249444.MethodsPubMed, Embase, World Health Organisation COVID-19 Global literature on coronavirus disease, and PsycINFO were searched between January 2020 and 7 April 2021 for multimorbidity and 1 February 2022 for frailty. Quantitative peer-reviewed studies published in English with population-representative samples and validated multimorbidity and frailty tools were considered.ResultsOverall, 9,701 records were screened by title/abstract and 267 with full text. Finally, 14 studies were retained for multimorbidity (etiological role, n = 2; prognostic, n = 13) and 5 for frailty (etiological role, n = 2; prognostic, n = 4). Only short-term outcomes, mainly mortality, were identified. An elevated likelihood of poorer outcomes was associated with an increasing number of diseases, a higher Charlson Comorbidity Index, different disease combinations, and an increasing frailty level.DiscussionFuture studies, which include the effects of recent virus variants, repeated exposure and vaccination, will be useful for comparing the possible evolution of the associations observed in the earlier waves.